Total Assets Summary of Imunon, Inc.

Imunon, Inc.'s latest annual total assets in 2023 was 21.91 Million USD , down -50.16% from previous year.
Imunon, Inc.'s latest quarterly total assets in 2024 Q1 was 14.32 Million USD , down -34.64% from previous quarter.
Imunon, Inc. reported annual total assets of 43.97 Million USD in 2022, down -40.61% from previous year.
Imunon, Inc. reported annual total assets of 74.04 Million USD in 2021, up 97.31% from previous year.
Imunon, Inc. reported quarterly total assets of 9.69 Million USD for 2024 Q2, down -32.34% from previous quarter.
Imunon, Inc. reported quarterly total assets of 21.91 Million USD for 2023 FY, down -50.16% from previous quarter.

Annual Total Assets Chart of Imunon, Inc. (2023 - 2012)

Historical Annual Total Assets of Imunon, Inc. (2023 - 2012)

Year	Total Assets	Total Assets Growth
2023	21.91 Million USD	-50.16%
2022	43.97 Million USD	-40.61%
2021	74.04 Million USD	97.31%
2020	37.52 Million USD	-1.96%
2019	38.27 Million USD	-18.31%
2018	46.85 Million USD	-1.39%
2017	47.51 Million USD	54.02%
2016	30.84 Million USD	-37.08%
2015	49.02 Million USD	-26.49%
2014	66.69 Million USD	46.03%
2013	45.67 Million USD	80.1%
2012	25.35 Million USD	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	14.32 Million USD	-34.64%
2024 Q2	9.69 Million USD	-32.34%
2023 FY	21.91 Million USD	-50.16%
2023 Q3	24.65 Million USD	-14.16%
2023 Q2	28.72 Million USD	-31.79%
2023 Q1	42.1 Million USD	-4.25%
2023 Q4	21.91 Million USD	-11.1%
2022 Q3	60.53 Million USD	-7.34%
2022 Q1	64.34 Million USD	-13.11%
2022 Q4	43.97 Million USD	-27.35%
2022 FY	43.97 Million USD	-40.61%
2022 Q2	65.32 Million USD	1.53%
2021 Q1	73.04 Million USD	94.63%
2021 FY	74.04 Million USD	97.31%
2021 Q2	83.01 Million USD	13.65%
2021 Q3	79.46 Million USD	-4.27%
2021 Q4	74.04 Million USD	-6.82%
2020 Q2	46.72 Million USD	20.0%
2020 Q4	37.52 Million USD	0.68%
2020 FY	37.52 Million USD	-1.96%
2020 Q1	38.93 Million USD	1.72%
2020 Q3	37.27 Million USD	-20.22%
2019 Q2	43.58 Million USD	-3.98%
2019 FY	38.27 Million USD	-18.31%
2019 Q4	38.27 Million USD	-5.63%
2019 Q3	40.56 Million USD	-6.94%
2019 Q1	45.39 Million USD	-3.12%
2018 Q2	49.5 Million USD	12.53%
2018 Q1	43.99 Million USD	-7.4%
2018 FY	46.85 Million USD	-1.39%
2018 Q4	46.85 Million USD	14.53%
2018 Q3	40.91 Million USD	-17.37%
2017 Q2	29.65 Million USD	-3.71%
2017 FY	47.51 Million USD	54.02%
2017 Q4	47.51 Million USD	82.74%
2017 Q3	26 Million USD	-12.33%
2017 Q1	30.79 Million USD	-0.16%
2016 Q3	37.46 Million USD	-13.91%
2016 Q2	43.51 Million USD	0.43%
2016 Q1	43.32 Million USD	-11.62%
2016 FY	30.84 Million USD	-37.08%
2016 Q4	30.84 Million USD	-17.65%
2015 Q4	49.02 Million USD	-8.63%
2015 Q3	53.65 Million USD	-11.18%
2015 Q2	60.41 Million USD	1.05%
2015 Q1	59.78 Million USD	-10.36%
2015 FY	49.02 Million USD	-26.49%
2014 Q4	66.69 Million USD	-9.35%
2014 Q3	73.57 Million USD	-7.55%
2014 Q2	79.57 Million USD	45.46%
2014 Q1	54.7 Million USD	19.79%
2014 FY	66.69 Million USD	46.03%
2013 Q1	47.95 Million USD	89.12%
2013 FY	45.67 Million USD	80.1%
2013 Q3	47.43 Million USD	-7.02%
2013 Q2	51.01 Million USD	6.37%
2013 Q4	45.67 Million USD	-3.71%
2012 Q4	25.35 Million USD	0.0%
2012 FY	25.35 Million USD	0.0%

Peer Total Assets Comparison of Imunon, Inc.

Name	Total Assets	Total Assets Difference
uniQure N.V.	831.68 Million USD	97.365%
Agios Pharmaceuticals, Inc.	937.11 Million USD	97.661%
Amicus Therapeutics, Inc.	777.88 Million USD	97.182%
Atara Biotherapeutics, Inc.	165.5 Million USD	86.757%
bluebird bio, Inc.	619.16 Million USD	96.46%
Cara Therapeutics, Inc.	125.84 Million USD	82.583%
Editas Medicine, Inc.	499.15 Million USD	95.609%
IQVIA Holdings Inc.	26.68 Billion USD	99.918%
Mettler-Toledo International Inc.	3.35 Billion USD	99.347%
Myriad Genetics, Inc.	1.19 Billion USD	98.172%
Neurocrine Biosciences, Inc.	3.25 Billion USD	99.326%
Supernus Pharmaceuticals, Inc.	1.4 Billion USD	98.444%
Verastem, Inc.	149.71 Million USD	85.36%
Walgreens Boots Alliance, Inc.	81.03 Billion USD	99.973%
Waters Corporation	4.62 Billion USD	99.526%
Thermo Fisher Scientific Inc.	98.72 Billion USD	99.978%
Biogen Inc.	26.84 Billion USD	99.918%
Nektar Therapeutics	398.03 Million USD	94.493%
Perrigo Company plc	10.8 Billion USD	99.797%
Dynavax Technologies Corporation	997.09 Million USD	97.802%
Illumina, Inc.	10.11 Billion USD	99.783%
Corbus Pharmaceuticals Holdings, Inc.	28.27 Million USD	22.475%
Iovance Biotherapeutics, Inc.	780.35 Million USD	97.191%
Heron Therapeutics, Inc.	222.5 Million USD	90.149%
Unity Biotechnology, Inc.	65.69 Million USD	66.634%
BioMarin Pharmaceutical Inc.	6.84 Billion USD	99.68%
Sangamo Therapeutics, Inc.	165.32 Million USD	86.742%
Evolus, Inc.	188.99 Million USD	88.403%
Adicet Bio, Inc.	207.29 Million USD	89.427%
Aclaris Therapeutics, Inc.	197.4 Million USD	88.897%
Regeneron Pharmaceuticals, Inc.	33.08 Billion USD	99.934%
Esperion Therapeutics, Inc.	205.79 Million USD	89.35%
FibroGen, Inc.	423.52 Million USD	94.825%
Agilent Technologies, Inc.	10.76 Billion USD	99.796%
OPKO Health, Inc.	2.01 Billion USD	98.91%
Homology Medicines, Inc.	47.05 Million USD	53.422%
Geron Corporation	394.07 Million USD	94.438%
Alnylam Pharmaceuticals, Inc.	3.82 Billion USD	99.428%
Exelixis, Inc.	2.94 Billion USD	99.255%
Viking Therapeutics, Inc.	368.49 Million USD	94.052%
Anavex Life Sciences Corp.	154.38 Million USD	85.803%
Intellia Therapeutics, Inc.	1.3 Billion USD	98.315%
Zoetis Inc.	14.28 Billion USD	99.847%
Axsome Therapeutics, Inc.	588.23 Million USD	96.274%
Abeona Therapeutics Inc.	64 Million USD	65.754%
Vertex Pharmaceuticals Incorporated	22.73 Billion USD	99.904%
Kala Pharmaceuticals, Inc.	55.94 Million USD	60.825%
Ionis Pharmaceuticals, Inc.	2.99 Billion USD	99.267%
Sarepta Therapeutics, Inc.	3.26 Billion USD	99.329%
Corcept Therapeutics Incorporated	621.51 Million USD	96.473%
Halozyme Therapeutics, Inc.	1.73 Billion USD	98.735%
Blueprint Medicines Corporation	1.04 Billion USD	97.911%
Insmed Incorporated	1.32 Billion USD	98.352%
TG Therapeutics, Inc.	329.58 Million USD	93.35%
Incyte Corporation	6.78 Billion USD	99.677%
Emergent BioSolutions Inc.	1.83 Billion USD	98.805%

Global Stocks Search

Imunon, Inc. (0HUZ.L)

Total Assets Summary of Imunon, Inc.

Annual Total Assets Chart of Imunon, Inc. (2023 - 2012)

Historical Annual Total Assets of Imunon, Inc. (2023 - 2012)

Peer Total Assets Comparison of Imunon, Inc.